G1 Therapeutics
Why Robinhood?
You can watch GTHX and buy or sell other stocks, ETFs, and their options commission-free!About GTHX
G1 Therapeutics, Inc. engages in the development of small molecule therapeutics for the treatment of patients with cancer. Its products pipeline includes trilaciclib, rintodestrant, and lerociclib.
GTHX Key Statistics
Stock Snapshot
With a market cap of 377.22M, G1 Therapeutics(GTHX) trades at $7.15. The stock has a price-to-earnings ratio of -8.30.
During the trading day, G1 Therapeutics(GTHX) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 651.38K.
The stock's 52-week range extends from a low of $1.08 to a high of $7.19.
The stock's 52-week range extends from a low of $1.08 to a high of $7.19.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.